canvastriada.blogg.se - Infanrix hexa 6

#Infanrix hexa 6 series

In the case of a child with a clinically unstable evolving neurological disorder, withholding vaccination until the clinical situation has stabilised should be considered on an individual basis after careful consideration of the risks and benefits. It may, in this situation only, be given subcutaneously

Those with bleeding disorders, such as haemophilia The vaccine should be administered in accordance with the haematologist’s instructions.

Specialist advice should be sought for the following groups: The presence of a minor infection is not a reason to delay immunisation

Administration of Infanrix-hexa should be postponed in individuals suffering from a fever over 38☌.

Anyone with severe allergy (anaphylaxis) to a previous dose of this vaccine or other diphtheria, tetanus, pertussis, polio, hepatitis B or Hib containing vaccine, or a component of the vaccine.

Vaccine safety Infanrix-hexa should not be given to:

Refer to Appendix 2 in the current Immunisation Handbook for further details on catch-up schedules and doses. Infanrix-hexa is funded for use in catch-up schedules in infants and children up to 10 th birthday. Infanrix-hexa should not be administered to children after their 10 th birthday, or to adults. Three doses are required for an infant or child to be fully immunised. The vaccine is administered intramuscularly, into the vastus lateralis. Separate syringes and different injection sites should be used. Infanrix-hexa can be administered concurrently with other vaccines, including all the National Immunisation Schedule vaccines. After reconstitution, the vaccine should be injected promptly. The vaccine MUST be reconstituted by adding the entire contents of the supplied syringe to the vial containing the Hib pellet. Store as per cold chain between 2☌ to 8☌. Infanrix-hexa is funded for use in catch-up schedules for children up to their 10th birthday. Infanrix-hexa is not funded for special groups.

#Infanrix hexa 6 series

Infanrix ®-hexa is funded as part of the primary immunisation series from 6 weeks of age and is adminstered at 6 weeks, 3 and 5 months. Please click here for detailed T&C.Vaccine type: Combination subunit protein and inactivated virus vaccines Vaccine schedule and administration

You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. You should not use the information provided herein to diagnose, prevent, or cure a health problem. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals.